These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12646234)

  • 1. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
    Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
    Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active repression of methylated genes by the chromosomal protein MBD1.
    Ng HH; Jeppesen P; Bird A
    Mol Cell Biol; 2000 Feb; 20(4):1394-406. PubMed ID: 10648624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
    Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
    Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methyltransferase and demethylase in human prostate cancer.
    Patra SK; Patra A; Zhao H; Dahiya R
    Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a family of mammalian methyl-CpG binding proteins.
    Hendrich B; Bird A
    Mol Cell Biol; 1998 Nov; 18(11):6538-47. PubMed ID: 9774669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.
    Jiang CL; Jin SG; Lee DH; Lan ZJ; Xu X; O'Connor TR; Szabó PE; Mann JR; Cooney AJ; Pfeifer GP
    Genomics; 2002 Dec; 80(6):621-9. PubMed ID: 12504854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
    Auriol E; Billard LM; Magdinier F; Dante R
    Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
    Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
    Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.
    Hendrich B; Abbott C; McQueen H; Chambers D; Cross S; Bird A
    Mamm Genome; 1999 Sep; 10(9):906-12. PubMed ID: 10441743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
    Yu F; Zingler N; Schumann G; Strätling WH
    Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase and DNA methyltransferase in human prostate cancer.
    Patra SK; Patra A; Dahiya R
    Biochem Biophys Res Commun; 2001 Sep; 287(3):705-13. PubMed ID: 11563853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.